Effect of Maternal Voice on Physiological Indicators and Feeding Performance

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-28
SponsorAcibadem University

About this trial

This study aimed to determine the effect of maternal voice on physiological indicators and oral feeding performance in preterm infants.

Hypothesis 1 (H1): Preterm infants who listen to their mother's voice throughout the full oral feeding process have higher oxygen saturation levels than those who do not.

Hypothesis 2 (H2): Preterm infants who listen to their mother's voice throughout the full oral feeding process have lower heart rates than those who do not.

Hypothesis 3 (H3): Preterm infants exposed to maternal voice throughout the full oral feeding process have lower respiratory rates than those who are not exposed.

Hypothesis 4 (H4): Preterm infants exposed to maternal voice throughout the full oral feeding process have better feeding maturation than those who are not exposed.

Hypothesis 5 (H5): The percentage of nutrient intake in preterm infants exposed to maternal voice throughout the entire oral feeding process is higher than in those not exposed.

Hypothesis 6 (H6): The feeding time of preterm infants exposed to the mother's voice throughout the entire oral feeding process is shorter than that of those not exposed.

Hypothesis 7 (H7): The amount of food consumed per minute by preterm infants exposed to the mother's voice throughout the entire oral feeding process is greater than that of those not exposed.

Eligibility criteria

Qualifiers

Preterm infants born at gestational age ≥28 weeks and ≤34 weeks

Infants who are ≥30 postmenstrual weeks old at the time of enrollment

Infants weighing ≥1000 grams at the time of enrollment

Mothers aged 18 years or older

Disqualifiers

Preterm infants with congenital anomalies.

Infants with a family history of congenital hearing loss.

Infants diagnosed with intraventricular hemorrhage (grade 3-4) or -periventricular leukomalacia.

Infants who have had necrotizing enterocolitis requiring treatment.

Trial design

Treatments tested in this trial

  • Maternal voice
  • Control Group (standard feeding )

Treatment groups

50 Participants
are divided into 2 treatment groups

Sponsors and collaborators